SCHEMBL29637301

SCHEMBL29637301

FC(F)(F)COc1ccc(Br)nn1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.49
L3MBTL1 Q9Y468 2/20 0.44
CYP1A2 P05177 1/20 0.38
IL1B P01584 1/20 0.36
POLB P06746 1/20 0.35
MAPK1 P28482 1/20 0.35
MAPT P10636 4/20 0.34
NPSR1 Q6W5P4 1/20 0.34
ALDH1A1 P00352 3/20 0.33
KDM4E B2RXH2 2/20 0.33
MEN1 O00255 1/20 0.33
USP2 O75604 1/20 0.33
HSP90AA1 P07900 1/20 0.33
HSP90AB1 P08238 1/20 0.33
THRB P10828 1/20 0.33
G6PD P11413 1/20 0.33
ALOX15 P16050 1/20 0.33
CASP1 P29466 1/20 0.33
KMT2A Q03164 1/20 0.33
HSD17B10 Q99714 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23148685 1.00 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL10807143 0.78 NUDT1 (0.38) SMN1; SMN2IL1B
SCHEMBL29685778 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL16705085 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL5644659 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL28670107 0.77 SMN1; SMN2 (0.49) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL17157315 0.77 CYP1A2 (0.53) L3MBTL1CYP1A2POLBMAPK1MAPT
SCHEMBL19664476 0.76 SMN1; SMN2 (0.48) SMN1; SMN2L3MBTL1CYP1A2IL1BPOLB
SCHEMBL30956492 0.74 HTT (0.45) SMN1; SMN2POLBMAPTALDH1A1MEN1
SCHEMBL25220258 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3774741-B1 ANTIMALARIAL HEXAHYDROPYRIMIDINE ANALOGUES UCB Biopharma SRL (BE) 2022-06-08 EP disclosed